Targeted Drug Delivery for Cancer

Targeted Drug Delivery for Cancer ine chinangwa chekuvandudza kushanda kwekurapa uye kuderedza mhedzisiro nekuendesa mishonga yekurapa zvakananga kumasero egomarara, uku ichideredza kuratidzwa kune hutano tishu. Iyi nzira inoshandisa nzira dzakasiyana siyana, kusanganisira nanoparticles, masoja ekudzivirira chirwere, uye peptides, kusarudza kunanga maseru egomarara uye kuburitsa mishonga panzvimbo yebundu. Kusununguka kwakanangana uku kunowedzera kuwanda kwezvinodhaka mukati mebundu, zvichiita kuti zvive nani uye kuderedza systemic toxicity. Nhanganyaya yeTargeted Drug DeliveryMarapirwo eCancer akashanduka zvikuru nekufamba kwemakore, kubva kumishonga yechinyakare kuenda kunzira dzakaomarara senge. Targeted Drug Delivery for Cancer. Chinangwa chekutanga che Targeted Drug Delivery for Cancer ndeyekuwedzera kurapa kwemishonga uku uchideredza mhedzisiro yavo ine chepfu pamaseru ane hutano. Izvi zvinowanikwa nekuendesa zvinodhaka zvakananga kunzvimbo yebundu kana maseru egomarara, kuve nechokwadi chekuti mhedzisiro yemushonga inonangana painodiwa zvakanyanya. At Shandong Baofa Cancer Research Institute, takatsaurirwa kufambisira mberi iyi ndima kuburikidza netsvakiridzo itsva uye makiriniki application.Sei Targeted Drug Delivery Yakakosha?Traditional chemotherapy inowanzobatanidza systemic administration yezvinodhaka, zvinoreva kuti mishonga inotenderera mumuviri wose. Izvi zvinogona kutungamira kune akakosha mhedzisiro, sekurasikirwa kwebvudzi, kusvotwa, uye kudzvinyirira immune system, sezvo masero ane hutano anokanganiswawo nemishonga yechemotherapy. Targeted Drug Delivery for Cancer inopa akawanda akakosha mabhenefiti: Yakaderedzwa Maside Effects: Nekunanga maseru egomarara zvakananga, masero ane hutano anochengetedzwa, zvichitungamira kune mashoma uye mashoma akanyanya mhedzisiro. Kubudirira Kwekuita: Kuwedzera kwepamusoro kwemushonga kunogona kuendeswa zvakananga kunzvimbo yebundu, kuwedzera kushanda kwayo. Kuwedzeredzwa Kwevarwere Migumisiro: Kuita zvirinani uye kuderedzwa kwemhedzisiro kunogona kutungamira kukuvandudzwa kwehupenyu uye huwandu hwekupona kwevarwere vegomarara. Kukunda Kuramba Mishonga: Kusununguka kwakanangwa kunogona kubatsira kukunda nzira dzekuramba zvinodhaka izvo maseru egomarara anogona kukura nekufamba kwenguva.Mazano eKuunza Mishonga Yakanangwa Nzira dzakawanda dzinoshandiswa mu Targeted Drug Delivery for Cancer, imwe neimwe iine yakasarudzika nzira yekusarudza yakananga maseru egomarara: Passive TargetingPassive yakanangana neiyo yakasarudzika hunhu hwebundu tishu, senge inovuza tsinga uye kusagadzikana lymphatic drainage. Nanoparticles akagadzirirwa kushandisa aya maficha, achiunganidza zvakanyanya mu tumor microenvironment. Izvi zvinonziwo Enhanced Permeability and Retention (EPR) effect.Active TargetingActive targeting inosanganisira kushandura vatakuri vezvinodhaka vane ligand chaiyo, yakadai semasoja ekudzivirira chirwere, peptides, kana maaptamers, anosunga kune zvinogamuchirwa zvakanyanya pamasero ekenza. Kudyidzana uku kunofambisa kusarudzwa kwemutakuri wezvinodhaka nemasero egomarara. Maitiro aya anosanganisira:Antibody-Drug Conjugates (ADCs)ADCs ine masoja ekudzivirira chirwere anonyatsoziva aturu-associated antigen, akabatana nemushonga une simba wecytotoxic. Kamwe iyo ADC inosunga kune kenza yesero, inoiswa mukati, uye mushonga unoburitswa mukati mesero, zvichiita kuti sero kufa. Muenzaniso ndeweAdo-Trastuzumab Emtansine (Kadcyla) iyo inotarisa HER2-positive cancer cancer cells [1].Ligand-Receptor InteractionsMasero eCancer anowanzo wedzera mamwe mareceptor pamusoro pavo. Nekubatanidza ligands (mamorekuru anosunga kune aya mareceptor) kune vanotakura zvinodhaka, zvinokwanisika kunanga mushonga wacho zvakananga kune aya maseru ekenza. Folate receptors uye transferrin receptors ndizvo zvinowanzoitika zvinangwa [2] .Stimuli-Responsive DeliveryStimuli-inopindura maitiro ekutumira zvakagadzirirwa kusunungura zvinodhaka chete kana zvichikonzerwa nemafungiro chaiwo aripo mu tumor microenvironment, zvakadai sepH kuchinja, basa re enzyme, kana redox. Izvi zvinova nechokwadi chekuti mushonga unoburitswa panzvimbo yebundu chete, zvichideredza mhedzisiro. Mienzaniso inosanganisira kushandisa pH-sensitive liposomes inoburitsa mubhadharo wavo munzvimbo ine acidic yemamota [3].Nanoparticles in Targeted Drug DeliveryNanoparticles inoita basa rakakosha Targeted Drug Delivery for Cancer. Aya madiki madiki, anowanzo kubva pa1 kusvika ku100 nanometers muhukuru, anogona kugadzirwa kuti atakure mishonga uye nekusarudza aendese kumaseru egomarara. Mhando dzakasiyana dze nanoparticles dzinoshandiswa, imwe neimwe iine zvayakanakira: Liposomes: Spherical vesicles inoumbwa nelipid bilayers, liposomes inogona kuvharira ese ari maviri hydrophilic uye hydrophobic zvinodhaka. Polymeric Nanoparticles: Yakagadzirwa kubva kune biodegradable polymers, aya nanoparticles anopa anodzorwa kuburitswa kwezvinodhaka uye kusimbaradzika. Quantum Dots: Semiconductor nanocrystals ine yakasarudzika optical zvivakwa, quantum dots inogona kushandiswa kufungidzira uye kuendesa zvinodhaka. Carbon Nanotubes: Cylindrical structures made of carbon atoms, carbon nanotubes can be functionalized with targeting ligands and drug.Examples of Targeted Drug Delivery SystemsSeveral Targeted Drug Delivery for Cancer masisitimu parizvino ari mukushandiswa kwekiriniki kana pasi pekuvandudzwa: Doxil/Caelyx: Liposomal doxorubicin, yakabvumidzwa kurapwa kwegomarara reovarian, Kaposi's sarcoma, uye akawanda myeloma [4]. Kuumbwa kwayo liposomal kunoderedza cardiotoxicity kana ichienzaniswa neyechinyakare doxorubicin. Abraxane: Albumin-bound paclitaxel, inoshandiswa kurapa kenza yemazamu, isiri-diki kenza yemapapu yemapapu, uye kenza yepancreatic [5]. Iyo albumin inosunga inosimudzira kuendeswa kwezvinodhaka kunzvimbo yebundu.Challenges uye Future DirectionsWhile Targeted Drug Delivery for Cancer ane vimbiso huru, matambudziko mazhinji asara: Tumor Heterogeneity: Maseru eCancer mukati mebundu anogona kuratidza hunhu hwakasiyana, zvichiita kuti zviome kunanga maseru ese nemazvo. Kuramba Mishonga: Masero egomarara anogona kukudziridza kuramba kune anonangwa marapirwo nekufamba kwenguva. Delivery Barriers: Kusvika panzvimbo yebundu kunogona kunetsa nekuda kwezvipingamupinyi zvemuviri, senge ropa-brain barriers. Kuwedzera uye Kugadzira: Kugadzira zvirongwa zvekuendesa zvinodhaka zvakanangwa pamwero mukuru zvinogona kuve zvakaoma uye zvinodhura.Kuedza kwekutsvaga kweramangwana kunotariswa pane: Kugadzira nzira dzakaoma kunzwisisa dzekutarisa kukunda bundu heterogeneity. Kubatanidza marapirwo anonangwa nedzimwe nzira dzekurapa, senge immunotherapy. Kugadzira stimuli-inopindura kuendesa masisitimu ayo anogona kuenderana nekuchinja tumor microenvironment. Kuvandudza scalability uye kudhura-kushanda kwekugadzira kwakanangwa nzira dzekutumira zvinodhaka.Basa reShandong Baofa Cancer Research InstituteAt. Shandong Baofa Cancer Research Institute, isu takabatikana mukutsvagisa nekuvandudzwa kwerinoveli Targeted Drug Delivery for Cancer zvirongwa. Chikwata chedu chemasayendisiti nevarapi vari kushanda kuti vakunde zvimhingamipinyi zvataurwa pamusoro apa uye kushandura zvakawanikwa mutsvakiridzo inovimbisa mumakiriniki. Tinotenda izvozvo Targeted Drug Delivery for Cancer inzira inokosha yekuvandudza migumisiro yekurapa kenza uye kuwedzera hupenyu hwevarwere vekenza.MhedzisoTargeted Drug Delivery for Cancer inomiririra kufambira mberi kwakakosha mukurapa cancer, ichipa mukana wekuvandudza kushanda uye kuderedza mhedzisiro. Nekusarudza kunanga maseru egomarara, masisitimu aya anogona kuendesa yakakwira kuwanda kwemishonga zvakananga kunzvimbo yebundu, zvichitungamira kune zvirinani kuvarwere. Nepo zvimhingamipinyi zvichiripo, tsvakiridzo nebudiriro irikuenderera mberi iri kugadzirira nzira yekurapa kwegomarara rinoshanda uye remunhu. National Cancer Institute - Antibody-Drug Conjugates Targeting folate receptor yekurapa cancer pH-sensitive liposomes yekurapa cancer. European Medicines Agency - Doxil FDA - Abraxane Prescribing Information